A groundbreaking brain tumour test can now diagnose patients in just two hours, a massive improvement from the previous eight-week wait. Developed by the Brain Tumour Research Centre of Excellence at the University of Nottingham, this rapid genomic test is being hailed as "gamechanging" by scientists and has already begun piloting within the NHS.
How the Rapid Brain Tumour Test Works
The test analyses the genetic code of a tumour sample in a matter of hours, providing a diagnosis while the patient is still on the operating table. This intraoperative diagnosis allows surgeons to make immediate decisions about the extent of tumour removal and enables patients to start treatment much sooner.
Traditionally, patients waited up to eight weeks for results, causing anxiety and delaying critical care. The new test eliminates this waiting period, reducing it to just two hours. Professor Frankie Swords, NHS medical director, called it "a huge leap forward for patients" with the "potential to completely transform how we diagnose brain tumours."
Benefits for Patients and the NHS
The rapid test not only speeds up diagnosis but also secures early access to clinical trials for certain patients. It reduces uncertainty and allows treatment to begin earlier, which can save lives. The NHS has begun using the tool in five specialist centres, with plans to roll it out more widely.
- Faster diagnosis: Reduces wait from eight weeks to two hours.
- Earlier treatment: Patients can start therapy sooner, improving outcomes.
- Reduced anxiety: Eliminates the stressful waiting period.
- Clinical trial access: Enables quicker enrollment for eligible patients.
Comparison: Traditional vs. Rapid Brain Tumour Diagnosis
| Aspect | Traditional Method | Rapid Genomic Test |
|---|---|---|
| Time to diagnosis | Up to 8 weeks | 2 hours |
| Treatment start | Delayed | Immediate |
| Patient anxiety | High due to waiting | Reduced |
| Clinical trial access | Limited | Enhanced |
Expert Opinions and Future Rollout
Stuart Smith, consultant neurosurgeon at Nottingham University Hospitals NHS Trust, expressed pride in the team's achievement: "I am very proud to have been part of this exceptional team creating this rapid genomic test." The pilot in five specialist centres will evaluate the test's effectiveness before a nationwide rollout.
This innovation represents a significant step forward in cancer care, potentially serving as a model for other rapid diagnostic tools. With brain tumours often aggressive, time is of the essence, and this test gives patients the fighting chance they deserve.
FAQ
What is the new brain tumour test?
The new test is a rapid genomic test that analyses the genetic code of a tumour sample in two hours, providing a diagnosis while the patient is still in surgery.
How does the rapid test reduce diagnosis time?
It eliminates the need to send samples to a lab and wait for results, cutting the wait from up to eight weeks to just two hours.
Where is the test available?
NHS England is piloting the test in five specialist centres, with plans to expand it nationwide if successful.